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Abstract: Colorectal cancer is the second leading cause of cancer death in the United States. 
Significant limitations in screening and surveillance modalities continue to hamper early 
detection of primary cancers or recurrences after therapy. In this study, we describe a new 
registered ultrasound (US) and acoustic-resolution photoacoustic microscopy (AR-PAM) 
system and report its initial testing in ex vivo human colorectal tissue. A total of 8 colorectal 
specimens were imaged, which included 2 polyps, 4 malignant colon cancers, and 2 treated 
colorectal cancers. In each specimen, normal tissue was also imaged for internal control. 
Initial data have demonstrated the feasibility of identifying colorectal cancer imaging features 
and the invasion depth using co-registered US and an AR-PAM system. In normal tissue, we 
found that our system consistently demonstrates the multi-layer structure of normal colonic 
tissue while differentiating layers with elevated vascularity; these findings highly correlated 
with histologic findings of each specimen. For malignant colorectal samples, the tissue 
structure is highly disorganized as seen in US, and photoacoustic imaging revealed distorted 
vascular distribution inside the tumor. Notably, AR-PAM of tumor beds after complete tumor 
destruction by radiation and chemotherapy yielded a pattern identical to benign tissue. 
Quantitative analysis of photoacoustic spectral slope has demonstrated more high-frequency 
components in malignant tissue as compared to the normal colon tissue, which may be caused 
by significantly increased microvessel networks. In summary, we demonstrate the successful 
differentiation of benign and malignant colorectal tissue with our co-registered ultrasound and 
photoacoustic system. 
© 2018 Optical Society of America under the terms of the OSA Open Access Publishing Agreement 
1. Introduction 
Photoacoustic imaging (PAI) techniques have demonstrated a unique ability to resolve optical 
absorption contrast in biological tissues [1,2], which can be invaluable for detection and 
diagnosis of tumor microvasculature or tumor angiogenesis [3,4]. PAI technique is based on 
the photoacoustic principle: as pulsed laser is delivered to tissue, photon energy absorbed by 
biomolecules converts to heat and creates an initial pressure wave [5]. This wave is detectable 
by an ultrasonic transducer. In tissue, PAI transforms hemoglobin into an endogenous 
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contrast agent that can be used to determine various functional and anatomic characteristics 
not available with basic endoscopy. 
In general, photoacoustic microscopy (PAM) is classified into optical-resolution (OR) 
PAM and acoustic-resolution (AR) PAM [6]; AR-PAM is able to penetrate deeper than OR-
PAM due to the use of acoustic focusing rather than optical focusing through tissue. Previous 
groups have applied this technology to image the esophagus and gastrointestinal tract of small 
animals, but no prior applications in the human distal GI tract have been described [7] [8]. 
Clinically, PAI has the potential to detect, in real time, both anatomic and functional changes 
that are otherwise not captured by traditional radiographic techniques. 
Photoacoustic spectrum analysis (PASA) is a powerful tool to quantify and characterize 
tissue microstructural changes. Strohm et al has demonstrated distinct features of red blood 
cell (RBC) morphology and tissue architecture in photoacoustic spectrum [9]. Xu et al has 
shown that photoacoustic spectrum parameters of spectral intercept, midband-fit, and spectral 
slope can differentiate normal and fatty mouse livers [10]. Chitnis et al has systematically 
evaluated photoacoustic spectral intercept, spectral slope, and effective-absorber size in 
differentiating tissue constituents [11]. Our group has shown that photoacoustic and 
ultrasound spectral parameters can be used to characterize malignant and benign/normal 
ovarian tissues [12,13]. 
Colorectal adenocarcinoma is a common cancer with an estimated annual incidence of 
over 100,000 cases in the United States [14]. Though white light endoscopy and pelvic 
magnetic resonance imaging (MRI) are the current gold standard techniques for detecting and 
surveilling these tumors, both modalities have significant shortcomings. Endoscopy only 
detects abnormalities of the mucosal surface of the colon and provides no assessment of 
oncologic activity in deeper aspects of the bowel. Yet MRI, which provides cross-sectional 
imaging of the entire pelvis, cannot achieve a resolution less than 1.5cm, limiting its ability to 
evaluate the GI tract for small malignancies or abnormalities. Additionally, MRI is not 
specific for evaluating post-treatment cancers due to inability to distinguish viable tumor from 
residual scar and fibrous tissue [15]. This shortcoming, in particular, currently limits 
widespread utilization of a promising new treatment option in rectal cancer that avoids 
surgical intervention altogether. Therefore, there exists an urgent need for new modalities that 
allow high resolution evaluation of the colorectum at all levels. 
In this study, we report the development and initial clinical testing of an AR-PAM system 
suitable for human colorectal cancer imaging. We hypothesized that AR-PAM would provide 
new insight into both colonic and rectal morphology in the setting of both untreated and 
treated tumors. We utilized phantoms and freshly excised human colon and rectal tissue to 
test parameters of the AR-PAM system and examine imaging patterns in human tissue. We 
also developed a novel comparative mechanism using PAM spectral slopes to quantify 
differences between malignant and benign tissue. 
2. Materials and methods 
2.1 Design and construction of the AR-PAM system 
Our endoscopic AR-PAM design is shown in Fig. 1(a)-(c). A multi-mode fiber (1.5mm 
diameter, numerical aperture of 0.39) delivers 750nm laser pulse to the imaging head. At the 
distal end of the imaging head, a focused ring transducer (4.0mm O.D., f = 12.7mm, 20MHz) 
is installed on the side; a 45° rod mirror reflects the laser beam 90° to tissue surface through a 
center hole of the ring transducer. 10mJ laser pulse illuminates a tissue area of 0.6 cm2; 
surface optical influence is 16.7mJ/cm2, which is within safety standards [16]. 
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 Fig. 1. (a)AR-PAM imaging head, (b) forward imaging mode, (c) side-view image mode. 
Figure 1(a) inset shows a photograph of the AR-PAM imaging head. Figure 1(b) and 1(c) 
show the forward view and side view modes of the AR-PAM, respectively; forward view 
facilitates bench-top scanning while sideview mode is suitable for endoscope use. Forward 
view mode is used in this study. 
 
Fig. 2. AR-PAM system. 
The complete system is shown in Fig. 2. Light output from a Nd:YAG (Lotis TII) pumped 
Ti:Sapphire (15 Hz, 10 ns) laser tunable from 700 nm to 900 nm is focused by a convex 
lens  (f = 40mm) to a multi-mode fiber. Distal end of multimode fiber is fixed on the 
endoscopic AR-PAM. A pulser/receiver (Panametrics 5900PR) is used to amplify 
photoacoustic signal in PA mode and obtain ultrasound image in Pulse/Echo mode. 
Sequentially co-registered photoacoustic and ultrasound data are acquired by a DAQ card. 
Motor scanning is controlled through an analog output card (National Instrument PCI 6251). 
This system takes 7 seconds to finish an ultrasound B-scan and 56 seconds for a 
photoacoustic B-scan of 20mm. Scanning speed is limited by the 15 Hz laser system. 
2.2 Performance testing 
Initial calibration and testing of the AR-PAM system involved three steps. First, we 
performed Fourier transformation of the ultrasound echo from glass into water to determine 
ring transducer frequency. Second, we evaluated the lateral and axial resolution of the AR-
PAM system by imaging a 7µm diameter carbon fiber. The ultrasonic transducer focal point 
is placed in the carbon fiber horizontal plane and cross-sectional images of the carbon fiber 
were obtained. Axial and lateral resolution were then calculated based on these tests. Finally, 
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we tested the signal-to-noise ratio (SNR) at different target depths using a black cotton string 
in 0.4% intralipid solution. Starting at the level of the transducer, the distance between the 
transducer lens and the black string was increased by increments of 0.5mm. Photoacoustic A-
scan images were then used to calculate the SNR. 
2.3 Human colorectal samples 
After system testing and calibration was performed, we conducted a pilot study of ex vivo 
human colorectal specimens to evaluate tissue characteristics under AR-PAM imaging. 
Specimens were collected from consenting patients undergoing colon or rectal resection of a 
known neoplastic lesion at Washington University School of Medicine. This study was 
approved by the Institutional Review Board (IRB) at Washington University. Each specimen 
was evaluated prior to formalin fixation to preclude tissue architectural alteration. To protect 
the specimens from excessive breakdown prior to histologic evaluation, all the imaging was 
completed within one hour of surgery. Specimens were then fixed in formalin and processed 
under normal staining and sectioning protocols. Hematoxylin and eosin (H&E) staining was 
performed on all specimens. Additional immunohistochemistry was performed with CD31 
antibodies to highlight vascular structures on select specimens for correlation of vascular 
histology with photoacoustic findings. 
2.4 Data analysis 
Data were analyzed both qualitatively and quantitatively. Qualitative analysis included 
comparison of AR-PAM generated images with histology; specific attention was paid to the 
layers of the tissue as well as the vascular organization of the tissues in question. To facilitate 
quantitative analysis, we utilized a measure of photoacoustic power spectral slope [12]. To 
calculate this parameter, power spectra were derived from fast Fourier transformation (FFT) 
on photoacoustic beams. Then, we performed linear fitting of the spectra in the range of 
transducer frequency responses. After the linear fitting, spectral slopes of each imaged 
malignant and benign area were then plotted using boxplot; Student t-test was used to 
calculate the statistical significance between malignant and normal group, as well as polyps 
and normal group, and p<0.05 was considered significant. 
3. Results 
3.1 AR-PAM calibration and testing 
Initial device performance testing demonstrated consistent characteristics across multiple tests 
(Fig. 3). Lateral and axial resolution were found to be 65µm and 45µm, respectively. In 0.4% 
intralipid solution (with an approximate 4 cm −1 reduced scattering coefficient), the signal-to-
noise ratio (SNR) varied from 42dB at 0.5mm to 18dB at 4.5mm. 
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 Fig. 3. (a) cross-sectional image of 7µm carbon fiber, (b) lateral resolution, (c) axial resolution, 
(d) depth test in intralipid, (e) SNR versus target depth 
3.2 Ex vivo sample imaging - qualitative analysis 
Eight specimens were imaged during this pilot study which included cancer without prior 
treatment, neoplastic polyps without malignancy, colon cancer after chemotherapy, and rectal 
cancer after radiation and chemotherapy (Table 1). Average imaging time of a 20mm cross 
sectional area of bowel was 1 minute. No system malfunctions or tissue damage occurred 
throughout the pilot study. 
Table 1. Summary of Specimen 
Case number Surgery Pathologic result Treatment 
method 
1 Sigmoid colectomy Adenomatous polyp with focus 
of adenocarcinoma 
N/A 
2 Right hemicolectomy T2N0 moderately 
differentiated adenocarcinoma 
N/A 
3 Sigmoid colectomy T3N1 adenocarcinoma Chemotherapy 
4 Low anterior resection Complete pathologic response - 
no residual tumor 
Radiotherapy and 
chemotherapy 
5 Sigmoid colectomy T3N0 adenocarcinoma N/A 
6 Total colectomy T3N1 adenocarcinoma N/A 
    
7 Right hemicolectomy Tubular adenoma N/A 
8 Right hemicolectomy Tubular adenoma N/A 
3.2.1. Colonic polyp 
Figure 4 displays several representative images obtained with the AR-PAM system on a 
segment of bowel (case 1) that included a known adenomatous polyp; both the polyp and a 
grossly normal segment of bowel were imaged. Photographs of these imaged areas (Fig. 4(a) 
and 4(e)) were collected at time of imaging; the white arrows indicate the plane through 
which the corresponding cross-sectional imaging was collected. 
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On ultrasound imaging alone, the normal layered structure of the colon wall appears to be 
clearly delineated (Fig. 4b). On the surface, the first two layers (L1 and L2) appear to 
represent the mucosal surface of the colon and likely includes the muscularis mucosa. Under 
the muscularis, the basement membrane (L3) appears echogenic (white) and overlies a thick 
hypoechoic layer (L4) corresponding to the submucosa. Finally, the deepest layer 
(approximately 1 mm from the endoluminal surface) is the muscularis propria (L5) and 
appears as the thickest layer. 
Figure 4(c) shows the same ultrasound image now co-registered with photoacoustic 
signals, demonstrating areas of vascular signal within the segment of bowel. Heavy 
concentrations of blood vessels are noted within the submucosa (indicated by high intensity 
of color); note also the relative paucity of signal within the underlying muscle. H&E images 
from the same specimen correlate with the co-registered ultrasound and AR-PAM images – 
the submucosa is rich in vascular structures while the underlying muscle lacks organized 
vessels (Fig. 4(d)). 
 
Fig. 4. Photograph of (a) normal colon and (e) adenomatous colon polyp; (b) ultrasound image 
of the normal tissue; (c) co-registered ultrasound and photoacoustic image of the same cross 
section of (b), white arrows refer to blood vessel in mucosa and yellow arrows refer to blood 
vessel in submucosa; (f) ultrasound image of polyp, tissue inside dashed line is polyp; (g) co-
registered ultrasound and photoacoustic image of the same cross section of (f); (d) and (h) are 
H&E images of normal tissue and polyp, yellow arrows identify blood vessels. 
Evaluation of the adenomatous polyp, however, shows two marked differences: loss of the 
organized layers seen in the normal colon and replacement with a peripherally vascularized 
but centrally quiescent, disorganized mass. In the standalone ultrasound image (Fig. 4(f)), the 
polyp (surrounded by dashed line) appears as an oval shape of disorganized tissue without 
distinguishable layers. On co-registered imaging, the photoacoustic signal pattern 
demonstrates loss of overall signal within the polyp (Fig. 4(g)). Note, however, the 
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hyperintensity within the submucosa of the normal bowel surrounding the polyp (outside the 
dashed white line). The lack of organized vascularity within the polyp correlates well with 
histology; relatively few vessels are noted within the polypoid tissue itself (Fig. 4(h)). In 
contrast to the normal, layered structure with consistent vascularity in the submucosa, the 
abnormal polyp appears disorganized and hypovascular on imaging with the AR-PAM 
system. Interestingly, there is an increase in photoacoustic signal surrounding the polyp, 
suggesting a hypervascular response to the neoplastic tissue. 
3.2.2. Colon cancer–no prior treatment 
AR-PAM found similar findings among imaged colon malignancies. Upon evaluation of a 
colon cancer confined to the superficial layers of the colonic wall, AR-PAM again 
demonstrated loss of layered structure as well as intra-lesion hypovascularity compared to 
normal tissue. Figure 5 shows the imaging results from one representative colon cancer 
specimen, case 2. 
 
Fig. 5. Gross photographic, ultrasound, coregistered, and CD31-stained histologic images of 
Specimen 2. (a) Photograph of the normal tissue, (b) ultrasound image of the normal tissue, (c) 
co-registered ultrasound and photoacoustic image of (b). (e) Photograph of cancer area, (f) and 
(g) are ultrasound and co-registered image of cancer. (d) and (h) are CD31 images of normal 
and cancer tissue, respectively, blue arrows point to blood vessels. 
Figure 5(f) and (g) correspond to ultrasound and co-registered images of the malignant 
lesion of this specimen. As in the polyp case, images of the normal bowel show consistent 
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layering with concentration of the vascular structures in the submucosa (Fig. 5(b)(c)). In 
contrast, tumor imaging shows loss of the normal layering as well as hypointense signaling 
from within the mass. Unlike the polyp, the tumor demonstrated markedly increased 
photoacoustic signal peripheral to the tumor, particularly on the mucosal surface. Histologic 
evaluation with CD31 targeted immunohistochemistry confirms these findings; heavy uptake 
of brown stain by endothelial lined blood vessels is noted at the mucosal surface of the tumor 
but remains centrally located in the submucosa of the normal specimen. 
3.2.3. Colon cancer–prior chemotherapy with residual disease 
Case 3 included a colon cancer previously treated with six cycles of chemotherapy that 
completed twenty days prior to surgical resection (Fig. 6 a-d). Figure 6(a) is a photograph of 
the ulcerated tumor bed surrounded by normal-appearing mucosa. Similar to previous lesions, 
ultrasound imaging across the lesion center demonstrated a peripheral multilayer structure 
that became disorganized within the actual tumor bed (central portion of Fig. 6(b) beneath the 
gel-filled ulcer cavity). Similarly, the co-registered photoacoustic image (Fig. 6(c)) also 
demonstrated relatively normal findings in the periphery; however, the regular photoacoustic 
signal distribution pattern transformed into hyperintense areas of high signal immediately 
around and below the ulceration (findings similar to non-treated cancerous tissues). 
Corresponding to the photoacoustic findings, histologic evaluation yielded a significant 
amount of residual cancer around the ulcerated cavity (Fig. 6(d)). In essence, the 
photoacoustic signal pattern appears to correlate with the malignant tissue found in proximity 
to the ulcer cavity. 
These images suggest that chemotherapy, in the absence of complete tumor death, does 
not reverse the alterations in AR-PAM signal noted in malignant tissue. 
3.2.4. Rectal cancer–prior chemotherapy and radiation without residual disease 
We also evaluated a rectal specimen (Case 4) with a known malignancy that had been treated 
with 2500 cGy of radiation and twelve cycles of chemotherapy before surgical resection (Fig. 
7(a-d)). The radiation, administered in 5 daily fractions, concluded 243 days prior to surgical 
resection and imaging. Gross evaluation demonstrated a pale, firm scar but no signs of active 
cancer (Fig. 7(a)). Unlike the previously described cancer specimens, both ultrasound and 
photoacoustic images yield a regularly layered structure with normal vascular distribution in 
the submucosa (Fig. 7(b) and 7(c)). In fact, these images appear much more similar to the 
patterns noted in the normal tissue in cases 1 and 2. Subsequent histologic evaluation of the 
specimen revealed no viable cancer cells; instead, the preoperative radiation and 
chemotherapy had completely destroyed the malignancy. Only fibrous scar tissue and mucin 
pools delineated the area of prior cancer (Fig. 7(d)). Blood vessels, labeled by yellow arrows, 
were noted throughout the submucosa. 
In other words, this specimen suggests that complete tumor death after treatment results in 
return of tissue to normal-appearing AR-PAM signal. Ultrasound detects standard layering of 
the bowel wall, and AR-PAM detects homogenous vascular signal within the submucosa- 
mirroring the findings of normal bowel. Significantly, scar tissue formed by the dead tumor 
does not appear to interfere with the return of normal vascular signal to these tissue areas. 
This may be a very significant finding, as it suggests a possible method for differentiating 
incomplete versus complete tumor responses. 
3.3 Quantitative analysis 
In addition to the qualitative comparisons reported above, we also used spectral slope to 
quantify differences between tissue types. Eight imaged areas – four neoplastic and four 
normal – were included in spectral slope calculations as described previously [12]. After 
deriving the center frequency of the transducer at 20 MHz with full width at half maximum 
(FWHM) from 12.5MHz to 27.5MHz, the linear fitting of spectrum in FWHM frequency 
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range was found in each specimen. Figures 8(c) and 8(e) demonstrate the range of PA signal 
from normal and cancer areas, respectively. Likewise, Figs. 8(d) and 8(f) show the power 
spectrum of signals demonstrated in 8(c) and 8(e). These power spectra were then combined 
to calculate a slope among all the cancer and all the normal tissues. For tumors, the median 
value of spectral slope (absolute value) of malignant group is significantly lower than that of 
normal tissue (0.9376 vs. 1.2551, respectively; p<0.01; Fig. 8(g) and Table 2). Table 2 
displays spectral slopes for each of the eight imaged areas previously described. Note that for 
boxplot Fig. 8(g), 4 cancer cases, 4 normal cases, 2 polyp cases, 1 treated rectal cancer case, 
and 1 residual of colon cancer case are included. Among them, 4 normal tissues are from non-
cancer normal areas of specimens with cancer. 
 
Fig. 6. Images obtained from select areas of Specimen 3 – a colon cancer treated with 
chemotherapy prior to resection. (a) Photograph of the post treated colon tumor area 
demonstrating a contracted, scarred ulcer, (b) ultrasound image of the lesion (note that 
ultrasound gel fills the ulcer cavity (dashed line) but is not within the tissue) (c) co-registered 
ultrasound and photoacoustic image demonstrating increased photoacoustic signal around the 
ulcerated area; (d) H&E image of the tumor bed showing residual islands of cancer cells (blue 
arrows within the dashed box) several millimeters beneath the surface of the specimen. 
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 Fig. 7. Images of Specimen 4 – a rectal cancer treated with chemotherapy and radiation prior to 
surgical resection; histologic evaluation revealed no viable tumor in the specimen. (a) 
Photograph of the post treated rectum tumor area, (b) ultrasound image of the lesion area, (c) 
co-registered ultrasound and photoacoustic image; (d) H&E image, no residual tumor is found, 
blood vessels are identified by yellow arrows. 
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 Fig. 8. (a) Ultrasound echo signal from glass; (b) fast Fourier transform of (a); (c) AR-PAM 
beam of normal tissue; (d) spectrum of (c); (e) AR-PAM beam of malignant tissue; (f) 
spectrum of (e); (g) Boxplot and P-value of photoacoustic spectrum slope (absolute value), 
including 4 malignant cases, 4 normal cases, 2 polyps cases, 1 treated case (rectal cancer with 
treatment) and 1 residual (colon cancer with treatment) 















Average value per case −1.1844 −1.2975 −1.0084 −1.1962 −1.2069 
 −0.9392 −1.2518 −1.0805   
 −0.6642 −1.2174    
 −0.9628 −1.2537    
Mean value −0.9376 −1.2551 −1.0444 −1.1962 −1.2069 
Standard deviation 0.2131 0.0328 0.0510   
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4. Discussion 
We report the initial design and testing of an acoustic resolution photoacoustic microscopy 
system on ex vivo human colon and rectum specimens. In addition to qualitatively describing 
the appearance of various histology when imaged with this system, we also report a method 
for quantitatively analyzing the different tissue profiles. Most importantly, these results 
suggest that AR-PAM may offer new discriminatory data to clinicians attempting to 
differentiate malignant from normal tissue in the human colon and rectum. 
4.1. System performance 
The AR-PAM system as described provides high resolution cross sectional photoacoustic and 
ultrasound imaging that also contains morphological data currently unavailable with 
traditional endoscopic or radiographic techniques. The system imaging head is designed as an 
endoscope for future human in vivo study. For current ex vivo sample study, forward viewing 
mode is used, however, for future in vivo endoscopic scanning of colon wall structures, the 
system can be operated in the side-viewing mode. The system resolution and penetration 
depth depend on the frequency of the ultrasound transducer. The system performance such as 
SNR was tested by imaging a black string inside calibrated intralipid solution at different 
depths of up to 4.5 mm, and the axial as well as lateral resolution were measured by imaging 
a carbon fiber. We obtained 18 to 42 dB SNR with a laser fluence well below the safety 
threshold, suggesting the ability to safely use this technology endoscopically in future in vivo 
patient study without averaging. Both lateral and axial resolutions are on the level of tens of 
microns, which is detailed enough to resolve colon wall structure and vasculature distribution. 
Blood vessels with a size smaller than the resolution, however, cannot be identified. Tissue 
penetration is about 8mm, which sufficiently images the submucosa and underlying muscle 
layer. Ultrasound imaging resolution and depth are on the same level as photoacoustic 
imaging. For both imaging modes, photoacoustic and ultrasound signal are detected directly 
without going through second medium, such as mirror or prism for redirecting the sound 
wave and introducing losses; therefore, maximum acoustic energy can be detected by the 
ultrasound transducer, which optimizes system signal-to-noise ratio. 
4.2. Tissue characterization and differentiation 
AR-PAM demonstrated the potential to differentiate benign from malignant tissue types in 
this pilot study. Though the study population was limited, clear trends appear within our data. 
Qualitatively, malignancies appear associated with disrupted layering of the bowel wall and a 
paucity of photoacoustic signal within the tumor itself. Polyps also show less blood vessels 
within the masses and in surrounding tissue when compared to cancers, and the photoacoustic 
signal from polyps are weaker than cancer. This phenomenon may be due to hypermetabolic 
activity of cancers compared to polypoid lesions. As a result, cancers require higher vascular 
flow than polyps to support their growth, leading to more pronounced PAM signal. 
Quantitatively, the imaged cancers are also associated with spectral slopes less than 1, which 
even in this small sample varies significantly from normal tissue. These differences appear 
due to changes in both the architecture and vascularity of tumors which, even at early stages, 
appear detectable by AR-PAM. 
Interestingly, the changes observed in malignant tissue organization and vascularity may 
return to normal in the setting of significant response to chemotherapy and radiation. While 
the rectal tumor bed images from this study were collected after therapy – and thus lack 
baseline measurements for comparison, our findings suggest that treated lesions may regain 
normal layering and organized submucosal vasculature. Therefore, AR-PAM may be able to 
detect a complete response to medical therapy among rectal tumors – fulfilling a clinical need 
that current endoscopic and radiographic techniques cannot accomplish. 
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Ultimately, the clinical utility of this instrument lies in its ability to identify small foci of 
cancer to facilitate early diagnosis or new malignancy or incomplete response to 
chemotherapy and radiation. The inability to identify incomplete responders, for example, is 
the main inhibitor to widespread adoption of nonoperative management of rectal cancer, a 
truly breakthrough option which will revolutionize rectal cancer care. Based on these 
preliminary results, AR-PAM may be the solution that increases cancer detection rates while 
sparing patients from highly morbid surgery overall. 
4.3. Limitations 
This small pilot study has limitations. First, the study included a small number of specimens. 
While the patterns described above appear consistent across multiple specimens, these 
findings need to be further validated with a larger patient pool and in vivo. 
Second, the imaging speed is limited by the speed of the Ti:Sapphire laser (15Hz). In 
future, we plan to upgrade the laser system to kHz repetition rate, which can be used for in 
vivo patient studies. 
5. Summary 
Unlike existent technologies such as MRI, endorectal ultrasound, or white light endoscopy, 
AR-PAM appears to produce high resolution morphologic imaging that may assist in the 
detection of microscopic tissue clusters in the future. Initial data from ex vivo human 
colorectal tissue have demonstrated the feasibility of identifying colorectal cancer imaging 
features using a co-registered ultrasound and acoustic-resolution photoacoustic microscopy 
system. For malignant colorectal tissue, the cross-sectional structure is highly disorganized 
with central darkening of the photoacoustic signal inside the tumor. Quantitative analysis of 
photoacoustic spectral slope has demonstrated more high-frequency components in malignant 
tissue as compared to the normal colon tissue, which may be caused by significantly 
increased microvessel networks. For treated colorectal cancers, AR-PAM may identify 
completely responded lesions, which would significantly change surgical practice for these 
diseases. 
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